Frederic Ors is the founder of Aramis Biotechnologies. Aramis Biotechnologies has raised $30M in total funding. Latest round: Series A.
Frédéric Ors is the Co-founder and CEO of Aramis Biotechnologies, a Canadian biotechnology company founded in 2023 specializing in plant-based vaccine production. He also holds positions as Chairman, President, and Secretary at Aramis Biotechnologies, Inc., and is a director at Consortium Québécois sur la Découverte du Médicament. Ors led the company's Series A financing round in December 2024, securing $30 million.
Full founder directory · Investor directory · Company funding database · Fundraising library